In-silico investigation and drug likeliness studies of benzimidazole congeners: The new face of innovation

In-silico investigation and drug likeliness studies of benzimidazole congeners: The new face of innovation

Background: The primary driving force behind the development of several small molecules for the treatment of tuberculosis is multi-drug resistance. A new fluorinated heterocyclic benzimidazole derivative gives extensive pharmacological activity against the FtsZ protein. FtsZ is a new validated targe...

Full description

Bibliographic Details
Main Authors: Shankar Thapa, Shachindra L. Nargund, Mahalakshmi Suresha Biradar, Janmajay Banerjee, Dipanjan Karati
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Molecular docking
Benzimidazole
FtsZ
ADMET properties
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914823000552

Internet

http://www.sciencedirect.com/science/article/pii/S2352914823000552

Similar Items